| Net Cash Provided by (Used in) Operating Activities |
-45.2K |
USD |
-48.6% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
42K |
USD |
-16% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
500M |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Common Stock, Shares, Issued |
441M |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-3.22K |
USD |
-116% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
19.3K |
USD |
+83.9% |
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Valuation Allowance |
369K |
USD |
-72.1% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
369K |
USD |
-72.1% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
369K |
USD |
+16% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Authorized |
3M |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Interest Expense |
89.3K |
USD |
+12% |
Q2 2025 |
Q2 2025 |